Equally importantly, FGFBP1 can promote hepatocellular carcinoma metastasis [38], and patients with pancreatic cancer who express higher FGFBP1 levels have been shown to have a worse prognosis [39]. The gene discussed is FGFBP1; the disease is hepatocellular carcinoma.